IP Library Granted Patent US 7,341,832
Granted Patent B2
US 7,341,832 · App. 10/649,400 · Granted Mar 11, 2008

Genes involved in neuropsychiatric disorders

Assignee: The Board of Trustees of the Leland Stanford Junior University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,341,832
App. No.
10/649,400
Granted
Mar 11, 2008
Kind
B2
Abstract

The present invention provides methods for diagnosing mental disorders. The invention also provides methods of identifying modulators of mental disorders as well as methods of using these modulators to treat patients suffering from mental disorders.

Claims (13)

1. A method for diagnosing bipolar disorder in a subject, the method comprising the steps of:

(i) isolating a subject's brain tissue, wherein said tissue is selected from the subject's dorsal lateral prefrontal cortex;

(ii) contacting the subject's brain tissue with a nucleic acid probe that selectively associates with an mRNA encoded by a nucleic acid with 95% identity to the sequence of SEQ ID NO: 3;

(iii) detecting the level of said nucleic acid probe that associates with said mRNA; and

(iv) comparing the detected level of associated probe with a control, whereby if the detected level is significantly greater than the control, an increased likelihood that the subject has bipolar disorder is determined; and whereby, if the detected level is not significantly greater than the control, an increase in said likelihood is not determined by the method.

2. The method of claim 1 , wherein the subject is deceased.

3. A method for diagnosing bipolar disorder in a subject, the method comprising the steps of:

(i) isolating a subject's brain tissue, wherein said tissue is selected from the subject's dorsal lateral prefrontal cortex;

(ii) contacting the subject's brain tissue with a nucleic acid probe that selectively associates with an mRNA encoded by a nucleic acid with 95% identity to the sequence of SEQ ID NO: 1;

(iii) detecting the level of said nucleic acid probe that associates with said mRNA; and

(iv) comparing the detected level of probe with a control, whereby if the detected level is significantly greater than the control, an increased likelihood that the subject has bipolar disorder is determined; and whereby, if the detected level is not significantly greater than the control, an increase in said likelihood is not determined by the method.

4. The method of claim 3 , wherein the subject is deceased.

5. The method of claim 1 or 3 , wherein an increased likelihood of bipolar disorder is determined, and further comprising treating said subject for bipolar disorder following said determination.

Assignments (4)
CONFIRMATORY LICENSE Recorded Aug 31, 2010
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024913/0418 →
CONFIRMATORY LICENSE Recorded Aug 17, 2010
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024846/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2006
From: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, ON BEHALF OF THE PRITZKER NEUROPSYCHIATRIC RESEARCH DISORDERS CONSORTIUM
Reel/Frame 017749/0738 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2004
From: BUNNEY, WILLIAM E.; JONES, EDWARD G.; MOLNAR, MARGHERITA
To: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
Reel/Frame 014315/0506 →
Continuity (3)
Provisional Application 6045130600 · Feb 27, 2003
Provisional Application 6040687900 · Aug 28, 2002
Related Publication 20040110198A1 · Jun 10, 2004